207 related articles for article (PubMed ID: 25660155)
1. Phase I study of cisplatin, hyperthermia, and lapatinib in patients with recurrent carcinoma of the uterine cervix in a previously irradiated area.
van Meerten E; Franckena M; Wiemer E; van Doorn L; Kraan J; Westermann A; Sleijfer S
Oncologist; 2015 Mar; 20(3):241-2. PubMed ID: 25660155
[TBL] [Abstract][Full Text] [Related]
2. A phase I/II study of combined weekly systemic cisplatin and locoregional hyperthermia in patients with previously irradiated recurrent carcinoma of the uterine cervix.
de Wit R; van der Zee J; van der Burg ME; Kruit WH; Logmans A; van Rhoon GC; Verweij J
Br J Cancer; 1999 Jul; 80(9):1387-91. PubMed ID: 10424740
[TBL] [Abstract][Full Text] [Related]
3. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
[TBL] [Abstract][Full Text] [Related]
4. Phase II, open-label study of pazopanib or lapatinib monotherapy compared with pazopanib plus lapatinib combination therapy in patients with advanced and recurrent cervical cancer.
Monk BJ; Mas Lopez L; Zarba JJ; Oaknin A; Tarpin C; Termrungruanglert W; Alber JA; Ding J; Stutts MW; Pandite LN
J Clin Oncol; 2010 Aug; 28(22):3562-9. PubMed ID: 20606083
[TBL] [Abstract][Full Text] [Related]
5. Feasibility, toxicity, and preliminary results of weekly loco-regional hyperthermia and cisplatin in patients with previously irradiated recurrent cervical carcinoma or locally advanced bladder cancer.
Rietbroek RC; Bakker PJ; Schilthuis MS; Postma AJ; Zum Vörde Sive Vording PJ; Gonzalèz Gonzalèz D; Kurth KH; Bakker AJ; Veenhof CH
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):887-93. PubMed ID: 8598366
[TBL] [Abstract][Full Text] [Related]
6. Weekly systemic cisplatin plus locoregional hyperthermia: an effective treatment for patients with recurrent cervical carcinoma in a previously irradiated area.
Franckena M; De Wit R; Ansink AC; Notenboom A; Canters RA; Fatehi D; Van Rhoon GC; Van Der Zee J
Int J Hyperthermia; 2007 Aug; 23(5):443-50. PubMed ID: 17701535
[TBL] [Abstract][Full Text] [Related]
7. Phase I study with weekly cisplatin-paclitaxel and concurrent radiotherapy in patients with carcinoma of the cervix uteri.
Pignata S; Frezza P; Tramontana S; Perrone F; Tambaro R; Casella G; Ferrari E; Iodice F; De Vivo R; Ricchi P; Tramontana F; Silvestro G
Ann Oncol; 2000 Apr; 11(4):455-9. PubMed ID: 10847466
[TBL] [Abstract][Full Text] [Related]
8. An European Organisation for Research and Treatment of Cancer phase I study of lapatinib and docetaxel as neoadjuvant treatment for human epidermal growth factor receptor 2 (HER2) positive locally-advanced/inflammatory or large operable breast cancer.
Bonnefoi H; Zaman K; Debled M; Fiche M; Fournier M; Nobahar M; Pierga JY; Koch KM; Bartlett J; Zimmer A; Marreaud S; Bogaerts J; Cameron D
Eur J Cancer; 2013 Jan; 49(2):281-9. PubMed ID: 22999386
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix.
Fiorica J; Holloway R; Ndubisi B; Orr J; Grendys E; Boothby R; DeCesare S; LaPolla J; Hoffman M; Patel J
Gynecol Oncol; 2002 Apr; 85(1):89-94. PubMed ID: 11925125
[TBL] [Abstract][Full Text] [Related]
10. Results of concurrent chemotherapy and hyperthermia in patients with recurrent cervical cancer after previous chemoradiation.
Heijkoop ST; van Doorn HC; Stalpers LJ; Boere IA; van der Velden J; Franckena M; Westermann AM
Int J Hyperthermia; 2014 Feb; 30(1):6-10. PubMed ID: 24156619
[TBL] [Abstract][Full Text] [Related]
11. Phase I trial of concomitant vinorelbine, cisplatin, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies.
Mundt AJ; Rotmensch J; Waggoner SE; Yamada SD; Fleming GF
Gynecol Oncol; 2004 Mar; 92(3):801-5. PubMed ID: 14984944
[TBL] [Abstract][Full Text] [Related]
12. A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastases.
Lin NU; Freedman RA; Ramakrishna N; Younger J; Storniolo AM; Bellon JR; Come SE; Gelman RS; Harris GJ; Henderson MA; Macdonald SM; Mahadevan A; Eisenberg E; Ligibel JA; Mayer EL; Moy B; Eichler AF; Winer EP
Breast Cancer Res Treat; 2013 Nov; 142(2):405-14. PubMed ID: 24197661
[TBL] [Abstract][Full Text] [Related]
13. A phase I study of concurrent weekly topotecan and cisplatin chemotherapy with whole pelvic radiation therapy in locally advanced cervical cancer: a gynecologic oncology group study.
Rose PG; Sill MW; McMeekin DS; Ahmed A; Salani R; Yamada SD; Wolfson AH; Fusco N; Fracasso PM
Gynecol Oncol; 2012 Apr; 125(1):158-62. PubMed ID: 22198338
[TBL] [Abstract][Full Text] [Related]
14. A pilot feasibility study for cisplatin plus S-1 for the treatment for advanced or recurrent cervical cancer.
Yunokawa M; Katsumata N; Yamamoto H; Kodaira M; Yonemori K; Shimizu C; Ando M; Tamura K; Fujiwara Y
Cancer Chemother Pharmacol; 2013 May; 71(5):1369-74. PubMed ID: 23558943
[TBL] [Abstract][Full Text] [Related]
15. Phase one dose finding study of capecitabine (Xeloda), radiotherapy and cisplatin in the treatment of locally advanced squamous cervical cancer.
Stokes Z; Symonds P; Habeshaw T; Reed N; Curto J; Joynson C; Chan S
Gynecol Oncol; 2005 Jun; 97(3):790-5. PubMed ID: 15894361
[TBL] [Abstract][Full Text] [Related]
16. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.
Wessalowski R; Schneider DT; Mils O; Friemann V; Kyrillopoulou O; Schaper J; Matuschek C; Rothe K; Leuschner I; Willers R; Schönberger S; Göbel U; Calaminus G;
Lancet Oncol; 2013 Aug; 14(9):843-52. PubMed ID: 23823158
[TBL] [Abstract][Full Text] [Related]
17. Phase I trial of erlotinib combined with cisplatin and radiotherapy for patients with locally advanced cervical squamous cell cancer.
Nogueira-Rodrigues A; do Carmo CC; Viegas C; Erlich F; Camisão C; Fontão K; Lima R; Herchenhorn D; Martins RG; Moralez GM; Small IA; Ferreira CG
Clin Cancer Res; 2008 Oct; 14(19):6324-9. PubMed ID: 18829516
[TBL] [Abstract][Full Text] [Related]
18. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
[TBL] [Abstract][Full Text] [Related]
19. Maximum tolerated dose and early response - results of a phase I trial of paclitaxel and cisplatin with radiation therapy in carcinoma of the cervix.
Prasad E; Viswanathan PN; Rangad VF; Pavamani S; Ram TS
Clin Oncol (R Coll Radiol); 2009 Aug; 21(6):488-93. PubMed ID: 19386478
[TBL] [Abstract][Full Text] [Related]
20. Phase I trial of intravenous cisplatin-topotecan chemotherapy for three consecutive days in patients with advanced solid tumors: parallel topotecan escalation in two fixed platinum dosing schemes.
Pentheroudakis G; Briasoulis E; Karavassilis V; Mauri D; Tzamakou E; Rammou D; Pavlidis N
Chemotherapy; 2005 May; 51(2-3):154-61. PubMed ID: 15886476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
